Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $720.80 | Total: $3,604.00 |
| 1 | 10 | $610.56 | Total: $6,105.60 |
| 1 | 25 | $517.28 | Total: $12,932.01 |
| 1 | 50 | $440.96 | Total: $22,048.00 |
| 1 | 100 | $381.60 | Total: $38,160.02 |
Overview
Sembragiline (EVT-302) is a selective MAO-B inhibitor for the study of Alzheimer's disease (AD).
Chemical Properties
| Molecular Formula | C19H19FN2O3 |
| Molecular Weight | 342.36 |
| CAS Numbers | 676479-06-4 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1N(C[C@@H](NC(C)=O)C1)C2=CC=C(OCC3=CC(F)=CC=C3)C=C2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Borroni E, et al. Sembragiline A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease. J Pharmacol Exp Ther. 2017 Sep;362[3] 413-423.